Home/Pipeline/ABS-201

ABS-201

Androgenetic Alopecia (Hair Loss)

PreclinicalActive

Key Facts

Indication
Androgenetic Alopecia (Hair Loss)
Phase
Preclinical
Status
Active
Company

About AbSci

Absci's mission is to create better biologics for patients, faster by overcoming traditional drug discovery bottlenecks. The company has evolved from its synthetic biology roots into an integrated AI biotech, building a proprietary data 'moat' and a closed-loop platform that designs and validates drug candidates in iterative six-week cycles. Its strategy leverages this platform to advance an internal pipeline and forge strategic partnerships, positioning it at the forefront of AI-driven therapeutic design.

View full company profile

Other Androgenetic Alopecia (Hair Loss) Drugs

DrugCompanyPhase
Revian SystemKNOW BioApproved